Page 5 - Heart Failure Protocols
P. 5

Pediatric Heart Failure Guidelines

               Neuromuscular Disorder Associated Cardiomyopathy ..............................................................20
                  Additional Evaluation for Patient with Neuromuscular Disorder associated Cardiomyopathy .20
                  Medical Management for Neuromuscular Associated Cardiomyopathy .................................20

               Myocarditis ................................................................................................................................21
                  Additional Evaluation for possible Myocarditis .......................................................................21
                  Medical Management Myocarditis .........................................................................................22
                  Immunotherapy Management Myocarditis .............................................................................22
                  Follow-up Schedule for Myocarditis .......................................................................................22
               Medication Doses .....................................................................................................................23
               Anticoagulation Schedules ........................................................................................................25



























































               Updated 3/1/2018                                                                        page 5
   1   2   3   4   5   6   7   8   9   10